AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glipisafe 500mg/50mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Genuwin Lifesciences

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Glipisafe 500mg/50mg Tablet SR

Diabetex Duo 500mg/50mg Extended-Release Tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like nephropathy and vision impairment, potentially lessening the risk of cardiovascular events. Diabetex Duo may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood sugar readings, and other concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Effective blood sugar control helps prevent future complications. Continued commitment to your prescribed diet and exercise plan is crucial. Lifestyle choices are integral to diabetes management. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal distress, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, especially when used with insulin or sulfonylureas; learn to recognize and manage this condition. This medication isn't suitable for all patients. Inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic issues, or significant alcohol consumption before initiating treatment. Pregnant or lactating women should seek medical advice prior to use. Potential drug interactions necessitate complete disclosure of all medications to your doctor for safety. Alcohol should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be conducted throughout your treatment.

Primary Ingredients of Glipisafe 500mg/50mg Tablet SR

No information provided. Please provide the text you wish to be rephrased.

Uses of Glipisafe 500mg/50mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glipisafe 500mg/50mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glipisafe 500mg/50mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this medication with food.

Common Side effects of Glipisafe 500mg/50mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Glipisafe 500mg/50mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. Consume Glipisafe 500mg/50mg Extended-Release Tablet with food.

How Glipisafe 500mg/50mg Tablet SR works:

Glipizide and metformin 500mg/50mg extended-release tablets (Glipisafe) offer a dual-action approach to blood sugar management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glipisafe 500mg/50mg SR tablet use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glipisafe 500mg/50mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glipisafe 500mg/50mg tablet is likely unsuitable for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when taking Glipisafe 500mg/50mg Tablet SR. A modified dosage of Glipisafe 500mg/50mg Tablet SR might be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Use of Glipisafe 500mg/50mg SR tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Glipisafe 500mg/50mg Tablet SR :

Should you forget a Glipisafe 500mg/50mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glipisafe 500mg/50mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glipisafe 500mg/50mg Tablet SR

Glipisafe 500mg/50mg SR tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may indicate hypoglycemia. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Glipisafe 500mg/50mg Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without first talking to your doctor.
Glipisafe 500mg/50mg Tablet SR is contraindicated in patients allergic to its components or excipients. It should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.
Glipisafe 500mg/50mg SR tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts pancreatic insulin release. This combination is contraindicated in individuals under 18.
Glipisafe 500mg/50mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding Glipisafe in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glipisafe immediately and seek medical attention.
Prolonged Glipisafe 500mg/50mg Tablet SR use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia and neurological complications.
Glipisafe 500mg/50mg SR tablets are safe when used as directed by your doctor. However, even with proper use, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent issues to your doctor.
Glipisafe 500mg/50mg Tabl...
130
MRP 150
13% off